US 11207342
High density lipoprotein binding protein (Hdlbp/Vigilin) iRNA compositions and methods of use thereof
granted A61KA61K31/713A61P
Quick answer
US patent 11207342 (High density lipoprotein binding protein (Hdlbp/Vigilin) iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/713, A61P, A61P3/06